In vitro cytotoxicity and hemocompatibility studies of Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf biomedical shape memory alloys.
The in vitro cytotoxicity and hemocompatibility of the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf biomedical shape memory alloys (SMAs) were investigated by cell culture (L-929 fibroblast cell), hemolytic test and platelet adhesion test, with CP Ti as a reference material. The cytotoxicity test indicates that all the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs show over 94% cell viability for different incubation times (2, 4 and 7 days) in comparison with a negative control and CP Ti. The cell morphology observation shows good polygon-like adherent growth and proliferation of L-929 in the extracts of all the test samples and CP Ti. These results suggest excellent cytocompatibility for the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs. The hemolytic test reveals that the hemolysis ratios of the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf alloys are far less than 5%, so they cannot give rise to acute hemolysis. The platelet morphology observation shows almost the same adhered platelet morphology and activation ratio for the test samples in comparison with CP Ti, except the Ti-22Nb-6Hf alloy, which shows a lower activation ratio of platelets, indicating excellent blood compatibility. Therefore, it is proposed that the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs will be candidates to replace Ti-Ni for biomedical applications.